StockMarketWire.com - Goldman Sachs today reaffirms its buy investment rating on GlaxoSmithKline PLC [LON:GSK] and raised its price target to 2060p (from 1900p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk